White House Objects to FY2008 Intelligence Authorization Bill
Perhaps the clearest indication lately that intelligence oversight still matters is a new White House Statement of Administration Policy (pdf) expressing strong opposition to the FY2008 Intelligence Authorization bill.
“If this bill were to pass the House and the Senate and be presented to the President for signature, the President’s senior advisors would recommend that he veto the bill,” the Statement notes.
On issue after issue, from interrogation to congressional reporting, the White House indicates disapproval of the new legislation, which has already been accepted by a House-Senate conference and awaits a final vote in each house.
Among other things, “The Administration also objects to section 328, which attempts to use Congress’ power of the purse to circumvent the authority of the Executive Branch to control access to extraordinarily sensitive information.”
This provision, which represents something of a new milestone in intelligence oversight, would impose a “fence” on certain spending until the Administration briefs the intelligence committees on the Israeli strike on a Syrian facility. It was introduced by Rep. Pete Hoekstra (R-MI) and adopted on a bipartisan basis.
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.
As the efficacy of environmental laws has waned, so has their durability. What was once a broadly shared goal – protecting Americans from environmental harm – is now a political football, with rules that whipsaw back and forth depending on who’s in charge.
It takes the average person over 9 hours and costs $160 to file taxes each year. IRS Direct File meant it didn’t have to.
It’s paramount to balance both innovation capabilities and risk as we work towards ensuring that the U.S. bioeconomy is a priority area for both the Nation and for National Security.